20.77
Overview
News
Price History
Option Chain
Financials
Why SLP Down?
Discussions
Forecast
Stock Split
Dividend History
Simulations Plus Inc stock is traded at $20.77, with a volume of 278.66K.
It is up +1.66% in the last 24 hours and up +7.39% over the past month.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
See More
Previous Close:
$20.43
Open:
$20.55
24h Volume:
278.66K
Relative Volume:
0.75
Market Cap:
$418.44M
Revenue:
$66.98M
Net Income/Loss:
$9.65M
P/E Ratio:
43.27
EPS:
0.48
Net Cash Flow:
$10.19M
1W Performance:
+2.52%
1M Performance:
+7.39%
6M Performance:
+59.28%
1Y Performance:
-36.95%
Simulations Plus Inc Stock (SLP) Company Profile
Name
Simulations Plus Inc
Sector
Industry
Phone
661-723-7723
Address
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Compare SLP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SLP
Simulations Plus Inc
|
20.77 | 411.59M | 66.98M | 9.65M | 10.19M | 0.48 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-30-25 | Initiated | TD Cowen | Hold |
| Jul-15-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-15-24 | Initiated | Stephens | Overweight |
| Jul-29-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-16-24 | Initiated | JMP Securities | Mkt Perform |
| Jun-28-24 | Initiated | William Blair | Outperform |
| May-09-23 | Initiated | BTIG Research | Buy |
| Oct-26-21 | Upgrade | Craig Hallum | Hold → Buy |
| Jan-12-21 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-16-20 | Initiated | Raymond James | Outperform |
| Sep-08-20 | Initiated | Oppenheimer | Outperform |
| Jan-06-20 | Initiated | Craig Hallum | Buy |
View All
Simulations Plus Inc Stock (SLP) Latest News
How Simulations Plus is weaving AI into every stage of drug development - Stock Titan
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day - Business Wire
Aug Intraday: Should I buy Simulations Plus Inc stock nowTrade Signal Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
TCOM ANNOUNCEMENT: If You Have Suffered Losses in Trip.com Group Limited (NASDAQ: TCOM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
SLP Investor News: If You Have Suffered Losses in - GlobeNewswire
Johnson Fistel Investigates Simulations Plus for Potential Securities Law Violations - GlobeNewswire
Downgrade Watch: Will Simulations Plus Inc outperform during market rallies2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
ROSEN, LEADING INVESTOR COUNSEL, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action InvestigationSLP - marketscreener.com
Stephens Investment Management Group LLC Buys 124,264 Shares of Simulations Plus, Inc. $SLP - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Hold" by Brokerages - MarketBeat
Simulations Plus (NASDAQ:SLP) shareholders are up 12% this past week, but still in the red over the last five years - simplywall.st
Simulations Plus (NASDAQ:SLP) Share Price Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
Simulations Plus (SLP) Q1 2026 Earnings Transcript - The Globe and Mail
Aug PreEarnings: Should I invest in Simulations Plus Inc before earnings2025 Risk Factors & High Accuracy Swing Trade Signals - baoquankhu1.vn
How (SLP) Movements Inform Risk Allocation Models - Stock Traders Daily
Insider Buy: Will Simulations Plus Inc benefit from green energy policiesStock Surge & AI Enhanced Execution Alerts - baoquankhu1.vn
Weekly Recap: Will Simulations Plus Inc. stock maintain growth storySell Signal & Trade Opportunity Analysis - Bộ Nội Vụ
Simulations Plus (SLP) Upgraded to Strong Buy: Here's What You Should Know - Eastern Progress
Is Simulations Plus Inc. stock recession proof2025 Price Targets & Verified Stock Trade Ideas - Улправда
Simulations Plus, Inc. SEC 10-Q Report - TradingView — Track All Markets
Tranche Update on Simulations Plus, Inc.'s Equity Buyback Plan announced on January 4, 2023. - marketscreener.com
Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 29% Upside Potential in Healthcare Tech - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Bio-Techne (TECH) and Simulations Plus (SLP) - The Globe and Mail
SLP Stock Crashes on Q1 Earnings Miss, Software Headwinds Hurt Sales - sharewise.com
Simulations Plus, Inc. (NASDAQ:SLP) Q1 2026 Earnings Call Transcript - Insider Monkey
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... By GuruFocus - Investing.com Canada
Simulations Plus Inc (SLP) Q1 2026 Earnings Call Highlights: Navigating Revenue Challenges with ... - Yahoo Finance
Is Simulations Plus Inc. stock overvalued by current metricsJuly 2025 Closing Moves & Stepwise Swing Trade Plans - Улправда
Simulations Plus Q1 2026 Earnings Call Transcript - MarketBeat
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results - PharmiWeb.com
Simulations Plus (SLP) Reports Q1 Revenue Aligning with Expectat - GuruFocus
Simulations Plus, Inc. Q1 Profit Increases, But Misses Estimates - Nasdaq
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast By Investing.com - Investing.com Nigeria
Simulations Plus Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Simulations Plus Q1 2026 misses EPS forecast - Investing.com
Simulations Plus Inc (NASDAQ:SLP) Meets Q1 Revenue Target Amid Software Segment Decline - Chartmill
Can Simulations Plus Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Capital Efficiency Focused Ideas - Улправда
Simulations Plus: Overview of First Quarter Financial Results - Bitget
Simulations Plus: Fiscal Q1 Earnings Snapshot - KVUE
SLP Adjusts FY26 Revenue Forecast Between $79M and $82M - GuruFocus
Simulations Plus Fiscal Q1 Adjusted EPS, Revenue Decrease - MarketScreener
Simulations Plus earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Simulations Plus Posts Mixed Q1 2026 Results, Reaffirms Outlook - TipRanks
Simulations Plus (NASDAQ:SLP) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat - Investing.com Nigeria
Simulations Plus shares dip as Q1 earnings miss overshadows revenue beat By Investing.com - Investing.com South Africa
Simulations Plus Q1 revenue beats expectations - TradingView — Track All Markets
SLP: Analyst Maintains Rating and Raises Price Target to $19.00 - GuruFocus
Simulations Plus (NASDAQ:SLP) Price Target Raised to $19.00 - MarketBeat
Tributary Capital Management LLC Grows Stock Holdings in Simulations Plus, Inc. $SLP - MarketBeat
Will Simulations Plus Inc. stock benefit from green energy trendsMACD Trading Signals & Real-Life Case Studies You Can Follow - Улправда
Simulations Plus Inc Stock (SLP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):